Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rinsho Ketsueki ; 59(7): 895-898, 2018.
Artigo em Japonês | MEDLINE | ID: mdl-30078800

RESUMO

A 73-year-old female was hospitalized with thrombotic microangiopathy (TMA) diagnosis because of consciousness disturbance, anemia, thrombocytopenia, renal dysfunction, and electrocardiogram abnormality. The patient died on day 12 of the symptom onset. The immunohistochemical analysis of microclot found in the autopsy of coronary artery confirmed TMA. It was suggested that the relationship to collagen disease by antinuclear antibody positive and the necessity of initiating circulation management and plasma exchange immediately before approximately 1×104 of platelets for the prognosis. The findings suggested considering TMA at the time of an unidentified shock, particularly acute adrenal insufficiency.


Assuntos
Microangiopatias Trombóticas/diagnóstico , Idoso , Eletrocardiografia , Evolução Fatal , Feminino , Humanos , Troca Plasmática , Prognóstico
2.
Gan To Kagaku Ryoho ; 40(9): 1237-40, 2013 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-24047788

RESUMO

A 52-year-old woman had a primary neuroendocrine tumor, Grade 2(NET G2)with multiple liver metastases and a mesenteric tumor. Since no drugs were approved for NET at that time in Japan, we treated her with sunitinib after approval by the Ethics Committee of Mie University Hospital and obtaining informed consent. Sunitinib was administered at a daily dose of 37.5mg/day, but the dose was reduced to 12.5mg/day because of thrombocytopenia(G3)and neutropenia(G3). CT revealed stable disease after 3 months of treatment, but disease progression was observed after 11 months. The non-hematological toxicity was hypertension(G3), which was controlled with antihypertensive agents. Although there are no previous reports of the treatment of well-differentiated NET with sunitinib in Japan, sunitinib may be effective against this disease.


Assuntos
Antineoplásicos/uso terapêutico , Indóis/uso terapêutico , Neoplasias Primárias Desconhecidas/tratamento farmacológico , Tumores Neuroendócrinos/tratamento farmacológico , Pirróis/uso terapêutico , Diferenciação Celular , Progressão da Doença , Feminino , Humanos , Pessoa de Meia-Idade , Tumores Neuroendócrinos/patologia , Sunitinibe
3.
Rinsho Ketsueki ; 54(12): 2199-202, 2013 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-24452153

RESUMO

A 77-year-old man was admitted because of fever. A small number of large CD20-positive neoplastic cells were seen in the bone marrow specimen. Clinical symptoms improved with oral prednisolone. After 11 months, abdominal CT scan revealed a liver mass. The biopsy specimen from the liver mass showed diffuse infiltration of large CD20-positive neoplastic cells. The patient was diagnosed as having diffuse large B-cell lymphoma. It was of particular interest that only neoplastic B cells within small blood vessels in the liver mass were positive for CD5. The patient died of lymphoma three months after diagnosis.


Assuntos
Vasos Sanguíneos/patologia , Medula Óssea/patologia , Antígenos CD5/metabolismo , Neoplasias Hepáticas/patologia , Linfoma Difuso de Grandes Células B/patologia , Idoso , Biópsia , Humanos , Neoplasias Hepáticas/metabolismo , Linfoma Difuso de Grandes Células B/metabolismo , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...